PRF Pulpotomy Using Different Bioceramic Materials in Permanent Molars

NCT ID: NCT04784949

Last Updated: 2021-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study aimed to compare the clinical and radiographic outcomes of full pulpotmy after application of Biodentine, or MTA, or Portland cement above PRF membrane In permanent molars with irreversible pulpitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irreversible Pulpitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

permanent molar with symptomatic irreversible pulpitis
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Portland cement

pulpotomy with PRF and white Portland cement

Group Type EXPERIMENTAL

portland cement

Intervention Type PROCEDURE

pulpotomy with PRF and white Portland cement

Mineral trioxide aggregate

pulpotomy with PRF and Mineral trioxide aggregate

Group Type EXPERIMENTAL

Mineral trioxide aggregate

Intervention Type PROCEDURE

pulpotomy with PRF and white Mineral trioxide aggregate

Biodentine

pulpotomy with PRF and Biodentine

Group Type EXPERIMENTAL

Biodentine

Intervention Type PROCEDURE

pulpotomy with PRF and Biodentine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

portland cement

pulpotomy with PRF and white Portland cement

Intervention Type PROCEDURE

Mineral trioxide aggregate

pulpotomy with PRF and white Mineral trioxide aggregate

Intervention Type PROCEDURE

Biodentine

pulpotomy with PRF and Biodentine

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* spontaneous, lingering pain exacerbated by hot and cold , and/or radiating pain
* Responded to cold and electric pulp testing

Exclusion Criteria

* pain on palpation, percussion,
* mobility or swelling
* peridontall widening
* Teeth with marginal periodontitis or crestal bone loss
* resorption
* calcified canals
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fayoum University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Nageh

Lecturer of Endodontics

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of dentistry Fayoum University

Al Fayyum, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial. Acta Odontol Scand. 2013 Jan;71(1):130-6. doi: 10.3109/00016357.2011.654251. Epub 2012 Feb 20.

Reference Type BACKGROUND
PMID: 22339289 (View on PubMed)

Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P, Clarke M, El Karim IA. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: A systematic review. J Dent. 2019 Sep;88:103158. doi: 10.1016/j.jdent.2019.06.005. Epub 2019 Jun 20.

Reference Type BACKGROUND
PMID: 31229496 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRF Pulp

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940 NOT_YET_RECRUITING PHASE1
Biodentine Versus White MTA Pulpotomy
NCT01733420 COMPLETED PHASE3